Anish Bhatnagar - 27 Jul 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Chief Executive Officer, Director
Signature
/s/ Anish Bhatnagar
Issuer symbol
SLNO
Transactions as of
27 Jul 2022
Net transactions value
$0
Form type
4
Filing time
29 Jul 2022, 09:14:06 UTC
Previous filing
04 Apr 2022
Next filing
14 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Award $0 +1,100,000 $0.000000 1,100,000 27 Jul 2022 Common Stock 1,100,000 $0.1730 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth of the shares subject to the option shall vest on August 1, 2022 and each three-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.